l carnitine raise blood pressure L-Carnitine – L-Carnitine in the Secondary Prevention

The ideal candidate for GH-releasing peptide therapy at our clinic is an adult over 35 with subjective symptoms of GH decline (the before profile described earlier) who has had a baseline IGF-1 drawn confirming that GH axis optimization is clinically appropriate

maintain*

This immune privilege is attributed to their low expression of major histocompatibility complex class II molecules (MHC-II, specifically HLA-DR) and the absence of co-stimulatory molecules (CD80/CD86), supporting their capacity for immune evasion (Khoury et al., 2014)

They catalyze processes such as gluconeogenesis, fatty acid oxidation, and ketone body synthesis, particularly during carbohydrate shortfalls

Excessive copper exposure is a theoretical concern with long-term, high-dose use